English
日本語
signup
login
Repository
Search
Annotators
Editors
Evaluators
NEWS
Documentation
>
top
>
projects
>
hydroxychloroquine
> docs
hydroxychloroquine
Documents
(914)
JSON
TSV
source DB
source ID
text
size
updated at
# proj.
# Ann.
updated_at
PubMed
32378805
COVID-19 and toxicity from potential treatments: Panacea or poison. Since December 2019, coronavirus disease (COVID-19) has been increasingly spreading from its origin in Wuhan, China to many countrie
879 Bytes
2020-05-21
2
0
2021-01-18
PubMed
32378314
Early Experience of COVID-19 in Two Heart Transplant Recipients: Case Reports and Review of Treatment Options. The Coronavirus Disease 2019 (COVID-19) pandemic imposes special challenges to immunocomp
1.54 KB
2020-05-21
2
4
2021-01-18
PubMed
32376397
Seven recommendations to rescue the patients and reduce the mortality from COVID-19 infection: An immunological point of view. Now COVID-19 is causing a severe public health emergency and the mortalit
1.2 KB
2020-05-21
3
1
2021-01-18
PubMed
32376395
SARS-CoV-2 infection among patients with systemic autoimmune diseases. OBJECTIVES: This study aimed to evaluate the prevalence of clinically overt SARS-CoV-2 infection (COVID-19) among patients with s
1.51 KB
2020-05-21
3
4
2021-01-18
PubMed
32376394
Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review. Severe Acute Respiratory Syndrome related to Coronavirus-2 (SARS-CoV-2), coronavi
1.32 KB
2020-05-21
3
1
2021-01-18
PubMed
32480420
Challenges in the Management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic. The SARS-CoV-2-associated disease (COVID-19) is primarily manifested as a respiratory
1.24 KB
2020-06-04
3
9
2021-01-18
PubMed
32480326
Are type 1 interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19? BACKGROUND: The Coronavirus (COVID-19), (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)) h
1.24 KB
2020-06-04
22
3
2021-01-18
PubMed
32479900
Fatal arrhythmias: Another reason why doctors remain cautious about chloroquine/hydroxychloroquine for treating COVID-19. BACKGROUND: Early during the current COVID-19 pandemic, hydroxychloroquine (HC
1.31 KB
2020-06-04
2
3
2021-01-18
PubMed
32476080
The association between treatment with heparin and survival in patients with Covid-19. This study investigates the association between the treatment with heparin and mortality in patients admitted wit
1.68 KB
2020-06-04
2
0
2021-01-18
PubMed
32475347
Measurement of hydroxychloroquine in blood from SLE patients using LC-HRMS-evaluation of whole blood, plasma, and serum as sample matrices. BACKGROUND: Hydroxychloroquine (HCQ) is the standard of care
2.35 KB
2020-06-04
2
8
2021-01-18
Page 16